Supernus Pharmaceuticals | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Abbott USD 50.83B 1.76B 2025-06
ANI Pharmaceuticals USD 436.76M 18.14M 2025-06
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Eisai JPY 828.51B 12.91B 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Novo Nordisk 168.07B 29.53B 2025-06
Pacira USD 757.77M 40.77M 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Supernus Pharmaceuticals USD 1.06B 33.2M 2025-06
United Therapeutics USD 7.17B 366.4M 2025-06
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12


Supernus Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.